Artificial Intelligence: Illuminating the Depths of the Tumor Microenvironment

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2024 Aug 29

PMID 39210368

Authors

Ting Xie

Aoling Huang

Honglin Yan

Xianli Ju

Lingyan Xiang

Jingping Yuan

Affiliations

Soon will be listed here.

Abstract

Artificial intelligence (AI) can acquire characteristics that are not yet known to humans through extensive learning, enabling to handle large amounts of pathology image data. Divided into machine learning and deep learning, AI has the advantage of handling large amounts of data and processing image analysis, consequently it also has a great potential in accurately assessing tumour microenvironment (TME) models. With the complex composition of the TME, in-depth study of TME contributes to new ideas for treatment, assessment of patient response to postoperative therapy and prognostic prediction. This leads to a review of the development of AI's application in TME assessment in this study, provides an overview of AI techniques applied to medicine, delves into the application of AI in analysing the quantitative and spatial location characteristics of various cells (tumour cells, immune and non-immune cells) in the TME, reveals the predictive prognostic value of TME and provides new ideas for tumour therapy, highlights the great potential for clinical applications. In addition, a discussion of its limitations and encouraging future directions for its practical clinical application is presented.

References

Ansardamavandi A, Tafazzoli-Shadpour M . The functional cross talk between cancer cells and cancer associated fibroblasts from a cancer mechanics perspective. Biochim Biophys Acta Mol Cell Res. 2021; 1868(11):119103. DOI: 10.1016/j.bbamcr.2021.119103. View

Wu L, Saxena S, Awaji M, Singh R . Tumor-Associated Neutrophils in Cancer: Going Pro. Cancers (Basel). 2019; 11(4). PMC: 6520693. DOI: 10.3390/cancers11040564. View

Piansaddhayanon C, Koracharkornradt C, Laosaengpha N, Tao Q, Ingrungruanglert P, Israsena N . Label-free tumor cells classification using deep learning and high-content imaging. Sci Data. 2023; 10(1):570. PMC: 10460430. DOI: 10.1038/s41597-023-02482-8. View

Rostam H, Reynolds P, Alexander M, Gadegaard N, Ghaemmaghami A . Image based Machine Learning for identification of macrophage subsets. Sci Rep. 2017; 7(1):3521. PMC: 5471192. DOI: 10.1038/s41598-017-03780-z. View

Phan N, Huang C, Tseng L, Chuang E . Predicting Breast Cancer Gene Expression Signature by Applying Deep Convolutional Neural Networks From Unannotated Pathological Images. Front Oncol. 2021; 11:769447. PMC: 8673486. DOI: 10.3389/fonc.2021.769447. View

Pittet M, Michielin O, Migliorini D . Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022; 19(6):402-421. DOI: 10.1038/s41571-022-00620-6. View

Huang Z, Johnson T, Han Z, Helm B, Cao S, Zhang C . Deep learning-based cancer survival prognosis from RNA-seq data: approaches and evaluations. BMC Med Genomics. 2020; 13(Suppl 5):41. PMC: 7118823. DOI: 10.1186/s12920-020-0686-1. View

Chen Q, Yin H, Liu S, Shoucair S, Ding N, Ji Y . Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma. J Immunother Cancer. 2023; 10(12). PMC: 9730407. DOI: 10.1136/jitc-2022-005798. View

Brummel K, Eerkens A, de Bruyn M, Nijman H . Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer. 2022; 128(3):451-458. PMC: 9938191. DOI: 10.1038/s41416-022-02119-4. View

10.

Rakaee M, Adib E, Ricciuti B, Sholl L, Shi W, Alessi J . Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC. JAMA Oncol. 2022; 9(1):51-60. PMC: 9673028. DOI: 10.1001/jamaoncol.2022.4933. View

11.

Walsh L, Quail D . Decoding the tumor microenvironment with spatial technologies. Nat Immunol. 2023; 24(12):1982-1993. DOI: 10.1038/s41590-023-01678-9. View

12.

Heppner B, Untch M, Denkert C, Pfitzner B, Lederer B, Schmitt W . Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer. Clin Cancer Res. 2016; 22(23):5747-5754. DOI: 10.1158/1078-0432.CCR-15-2338. View

13.

Khorana A, Ryan C, Cox C, Eberly S, Sahasrabudhe D . Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer. 2003; 97(4):960-8. DOI: 10.1002/cncr.11152. View

14.

Elhanani O, Ben-Uri R, Keren L . Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell. 2023; 41(3):404-420. DOI: 10.1016/j.ccell.2023.01.010. View

15.

Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View

16.

Arvaniti E, Claassen M . Sensitive detection of rare disease-associated cell subsets via representation learning. Nat Commun. 2017; 8:14825. PMC: 5384229. DOI: 10.1038/ncomms14825. View

17.

Gurcan M, Pan T, Shimada H, Saltz J . Image analysis for neuroblastoma classification: segmentation of cell nuclei. Conf Proc IEEE Eng Med Biol Soc. 2007; 2006:4844-7. DOI: 10.1109/IEMBS.2006.260837. View

18.

Kather J, Pearson A, Halama N, Jager D, Krause J, Loosen S . Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med. 2019; 25(7):1054-1056. PMC: 7423299. DOI: 10.1038/s41591-019-0462-y. View

19.

Pure E, Blomberg R . Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018; 37(32):4343-4357. PMC: 6092565. DOI: 10.1038/s41388-018-0275-3. View

20.

Moen E, Bannon D, Kudo T, Graf W, Covert M, Van Valen D . Deep learning for cellular image analysis. Nat Methods. 2019; 16(12):1233-1246. PMC: 8759575. DOI: 10.1038/s41592-019-0403-1. View